Ardelyx, Inc.

ARDX·NasdaqGM·Healthcare
Compare
3.2900+0.2600 (+8.58%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market3.3500+0.0600 (+1.82%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3.0300
Open3.4100
Day range3.08503.4100
52-week range2.95508.4000
Off day high−3.52%
Off 52-week high−60.83%
Volume10.58M
Avg. volume (3M)4.66M
Market cap849.44M
EPS (TTM)-0.2300
Forward P/E11.18
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.77
Shares outstanding258.19M
Short interest11.96% of float
Earnings dateNov 3, 2026
Analyst target12.8000
Profit margin−12.35%

Against its peers

Compare in full ›
ARDX ANNX AVLN LXRX XSPRAY.ST ZVRA
Market cap 849.44M 820.88M 1.22B 658.53M 572.79M 663.32M
P/E (TTM) — — — — — 9.2
Forward P/E 11.2 -4.0 -10.6 -7.8 -7.6 10.4
Price/book 4.8 4.1 3.1 3.8 0.9 4.1
Dividend yield — — — — — —
1-year change −49.08% +39.20% −9.09% +5.80% −52.63% +1.89%
Today +8.58% +3.34% +2.46% +1.37% +0.33% +8.87%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Ardelyx's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Annexon, Inc.ANNX · Biotechnology 820.88M 4.3300 +3.34%
Avalyn Pharma Inc.AVLN · Biotechnology 1.22B 27.47 +2.46%
Lexicon Pharmaceuticals, Inc.LXRX · Biotechnology 658.53M 1.4800 +1.37%
Xspray Pharma AB (publ)XSPRAY.ST · Biotechnology 572.79M 12.08 +0.33%
Zevra Therapeutics, Inc.ZVRA · Biotechnology 663.32M 11.17 +8.87%
Arcus Biosciences, Inc.RCUS · Biotechnology 2.43B 19.31 +2.12%
Arrowhead Pharmaceuticals, Inc.ARWR · Biotechnology 8.71B 61.65 +3.56%
Ionis Pharmaceuticals, Inc.IONS · Biotechnology 6.67B 40.15 −0.67%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Wuhan YZY Biopharma Co., Ltd.2496.HK · Wuhan, China 775.40M 4.000 +5.26%
Annexon, Inc.ANNX · Brisbane, CA 820.88M 4.3300 +3.34%
Bambusa Therapeutics, Inc. Common stockBBTX · Boston, MA 799.67M 16.07 +0.44%
Inventiva S.A.IVA.PA · Daix, France 858.66M 3.6350 +2.54%
OmniAb, Inc.OABI · EmeryVille, CA 755.56M 5.18 +0.58%
Obsidian Therapeutics, Inc.OBX · Cambridge, MA 678.88M 10.99 −16.93%
Prime Medicine, Inc.PRME · Cambridge, MA 901.44M 4.9700 +9.23%
Corvus Pharmaceuticals, Inc.CRVS · South San Francisco, CA 889.16M 10.57 +7.53%

Also based in Waltham, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Thermo Fisher Scientific Inc.TMO · Waltham, MA 261.64B 706.16 +1.12%
Veralto CorporationVLTO · Waltham, MA 28.45B 117.02 +0.60%
Revvity, Inc.RVTY · Waltham, MA 17.79B 159.43 −2.48%
Repligen CorporationRGEN · Waltham, MA 11.39B 178.20 −0.04%
Spyre Therapeutics, Inc.SYRE · Waltham, MA 9.26B 99.04 −0.23%
Pegasystems Inc.PEGA · Waltham, MA 5.62B 34.36 +0.03%
Cogent Biosciences, Inc.COGT · Waltham, MA 5.46B 31.49 +1.38%
Crane NXT, Co.CXT · Waltham, MA 3.55B 61.62 +2.63%

Companies that serve the same markets: healthcare.

Company Mkt cap Price Today
Intuitive Surgical, Inc.I1SR34.SA · healthcare 935.13B 132.35 +7.60%
Emcure Pharmaceuticals LimitedEMCURE.BO · healthcare 424.98B 2,240.15 +3.02%
Krishna Institute of Medical Sciences LimitedKIMS.BO · healthcare 306.90B 730.70 −1.24%
PT Mitra Keluarga Karyasehat TbkMIKA.JK · healthcare 18.26T 1,315.00 +1.15%
PT Prodia Widyahusada TbkPRDA.JK · healthcare 3.20T 3,650.00 −1.35%
Ventas, Inc.V1TA34.SA · healthcare 244.47B 231.15 0.00%
BeOne Medicines AG6160.HK · healthcare 367.68B 248.600 +7.34%
Medy-Tox Inc.086900.KQ · healthcare 428.83B 66,400.00 +6.07%

What visitors to Ardelyx's page also look at.

Company Mkt cap Price Today
Akebia Therapeutics, Inc.AKBA 192.51M 0.6947 −4.28%
Aldeyra Therapeutics, Inc.ALDX 39.06M 0.6474 +4.32%
CytomX Therapeutics, Inc.CTMX 512.06M 2.3500 +7.80%
TG Therapeutics, Inc.TGTX 9.43B 61.63 +1.45%
KALA BIO, Inc.KALA 3.44M 0.1781 +2.95%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All ARDX news ›
www.pmg-ky3.com··3 outletsPositive

ARDELYX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure ...

NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the “Class…

ARDX
More from 2 other outlets
Seeking Alpha·

Ardelyx, Inc. (ARDX) Q3 2026 Earnings Call Transcript

Ardelyx, Inc. (ARDX) Q3 2026 Earnings Call November 3, 2026 4:30 PM ESTCompany ParticipantsLisa Caperelli - Senior Vice President of Investor Relations and... Ardelyx, Inc. (ARDX) Q3 2026 Earnings Call November 3, 2026 4:30 PM EST Lisa…

ARDXMSIRMDGS
The Globe and Mail·Negative

BTIG Remains a Buy on Ardelyx (ARDX)

BTIG analyst Julian Harrison maintained a Buy rating on Ardelyx yesterday and set a price target of $14.00. According to TipRanks, Harrison is a 5-star analyst with an average return of 38.9% and a 46.88% success rate. Harrison covers the…

ARDXMS
FinancialContent··2 outletsNegative

ARDX UPCOMING DEADLINE: SueWallSt Alerts Ardelyx, Inc. Stockholders of Securities Class Action - Contact the Firm

NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- SueWallSt alerts investors in Ardelyx, Inc. (NASDAQ: ARDX) of a pending securities class action. Class Period: January 13, 2025 through August 6, 2026. Check if you might be eligible to recover…

ARDXAVEX
More from 1 other outlet
Morningstar··3 outlets

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), ... ARDX Investors Have Opportunity to…

ARDXSPRY
More from 2 other outlets
Morningstar··2 outletsNegative

ARDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Ardelyx, Inc. Securities Lawsuit - Contact Levi & Korsinsky

NEW YORK, Oct. 7, 2026 Notice to pension funds, asset managers, and fiduciaries: the lawsuit contends Ardelyx maintained its long-term revenue outlook for XPHOZAH and IBSRELA while payer access barriers were allegedly building, before an…

ARDXAVEX
More from 1 other outlet

From the 4Search news index, newest first.

In the news

62mentions in 30 days
52with it in the headline
Mixedsentiment

Mentioned with

Rosen Law Firm61Lead Ardelyx, Inc58Ardelyx, Inc.54Iss Securities Class Action Services54Chinese Company Rosen Law Firm51Ardelyx, Inc36Aardvark Therapeutics, Inc32Aardvark25

People in the coverage

Rosen Law60Peretz Bronstein44Brian Schall43David Schwartz43Andrew Brown41Laurence Rosen38

Themes

New York52PR Newswire402025 and August 629Los Angeles28Aard27202525Operations24Avex21

Most coverage from

  1. prnewswire.com11
  2. globenewswire.com10
  3. newsfilecorp.com8
  4. accessnewswire.com6
  5. themarketsdaily.com4

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 62 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance